September 9, 2009in Infringement, Patentability, Patents, Pharmaceutical Drugs0by Editor777 Process or Product? Recent Product-by-Process Case May Pose Problems for Innovators The U.S. Court of Appeals for the Federal Circuit recently ended much of the controversy surrounding product-by-process claims in Abbott Laboratories v. Sandoz, Inc., but arguably created a new debate…
